Authors
Latest:
ARVO 2024: Taking stock of patients' nAMD experience using an activity inventoryAntonio Filipe Macedo, OD, MSc, PhD, speaks about his ARVO presentation on vision-related activity difficulties in patients with neovascular age-related macular degeneration
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
Pearls for management of Pseudomonas scleritisDr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis
Latest:
New goniotomy device + careful post-op care limits intraoperative bleedingA new device for goniotomy has the advantage of an irrigation/aspiration system, which offers easier excision of the trabecular meshwork and better visibility. Dr Desai shares his experiences using the device as well as his tips and surgical pearls for success.
Latest:
Worldwide pathological myopia discussed by panel at EURETINA 2021Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNewly developed acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Global partnership targets ROP in premature infantsAn AI-supported telemedicine effort from Siloam Vision and Orbis International
Latest:
New options are on the horizon for presbyopia-correcting dropsFor ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.
Latest:
Harnessing digital media for enhanced patient engagement and outcomesPatients who received digital education demonstrated a better understanding of their disease and its management
Latest:
Using pivotal study data to guide glaucoma patient management decisionsTwo randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Latest:
Digital visual training helps treat disorders associated with close workComputer software platform provides home vision exercises to overcome asthenopia.
Latest:
Letter to the Editor: Intravitreal injections. Who should perform them?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
First-ever retinal gene therapy: Does real-world experience back its use?Recent reports of retinal atrophy have raised concerns on potential long-term safety.
Latest:
ARVO 2024: Reliability of contact specular microscopy in the corneal endotheliumElias Kahan speaks about his ARVO poster, "Contact specular microscopy reliably images the same location of the corneal epithelium"
Latest:
Focusing on functional vision with monofocal lensesQuantitative and qualitative improvement in IOL design
Latest:
Short-term corticosteroid use can provide rapid relief of allergy symptoms in dry eye diseaseA short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.
Latest:
Cross-linking in paediatric patients: The case for treating keratoconus without waiting for disease progressionThe case for treating keratoconus without waiting for disease progression
Latest:
TEASE-3 study: Positive interim data are reported for Stargardt drugGildeuretinol halts Stargardt disease progression, study results indicate
Latest:
Distorted corneas: How to regularise them with minimally invasive surgerySequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations
Latest:
Gene therapy research ushers in new therapy options for retinal diseasesFoundation Fighting Blindness is a driving force in advancing retinal gene therapies into clinical trials.
Latest:
Risks and management of diabetic retinopathy in paediatric patientsDiabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.
Latest:
The impact of landmark studies on clinical practice in glaucomaLandmark randomised controlled trials have advanced the understanding and treatment of glaucoma.
Latest:
Landscape of genetic therapies for USH2A-related retinitis pigmentosaIncreasing understanding of the genetics behind Usher syndrome suggests that treatment may become possible in the very near future.
Latest:
Assessing barriers to retinal care during a pandemicA global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
Latest:
The ins and outs of gene therapy for inherited optic neuropathiesA look at what’s in the therapeutic delivery pipeline for these disorders.
